Abraham E
Sir William Dunn School of Pathology, University of Oxford.
Bioessays. 1990 Dec;12(12):601-6. doi: 10.1002/bies.950121208.
The discovery, made in Oxford, that crude penicillin could cure systemic and life-threatening bacterial infections was followed by attempts to purify penicillin, to determine its structure and then to produce it by total chemical synthesis. The beta-lactam structure of the molecule, first proposed in October 1943, was a source of controversy until 1945. However, no useful chemical synthesis was achieved and fermentation became the commercial source of the antibiotic. In 1953, one of the products of a Cephalosporium sp. from Sardinia was shown to be a new and hydrophilic penicillin (penicillin N). This was contaminated with a substance having the same side-chain but a characteristic absorption spectrum. The latter, cephalosporin C, showed antibacterial activity but was not inactivated by a penicillinase. The determination of its beta-lactam structure and isolation of its nucleus enabled pharmaceutical companies to produce many semisynthetic cephalosporins. A new tripeptide was later found to be an intermediate in the biosynthesis of both penicillin N and cephalosporin C, and this was followed by the complete elucidation of the biosynthetic pathways leading to these compounds and to benzylpenicillin.
在牛津发现粗制青霉素可治愈全身性及危及生命的细菌感染后,人们尝试对青霉素进行提纯、确定其结构,进而通过全化学合成来生产它。该分子的β-内酰胺结构于1943年10月首次提出,直到1945年一直存在争议。然而,当时并未实现有效的化学合成,发酵成为了这种抗生素的商业来源。1953年,来自撒丁岛的一种头孢菌属的产物之一被证明是一种新型亲水性青霉素(青霉素N)。它被一种具有相同侧链但特征吸收光谱的物质污染。后者,即头孢菌素C,具有抗菌活性,但不被青霉素酶灭活。其β-内酰胺结构的确定及其核心的分离使制药公司能够生产许多半合成头孢菌素。后来发现一种新的三肽是青霉素N和头孢菌素C生物合成的中间体,随后人们完全阐明了导致这些化合物以及苄青霉素的生物合成途径。